We have located links that may give you full text access.
ENGLISH ABSTRACT
JOURNAL ARTICLE
REVIEW
[Update on current care guidelines: atrial fibrillation].
New features in the Finnish guidelines for management of patients with atrial fibrillation (AF) include a recommendation to use the EHRA score in evaluation of AF-related symptoms and introduction of comprehensive CHA DS VASc and HAS-BLED scoring systems for stratifying the risk of thrombotic and bleeding complications, respectively. Recommendations on the use of two new antiarrhythmic drugs are included. Vernakalant is indicated for pharmacological cardioversion and dronedarone for prevention of AF. They can be used by patients with cardiac disease, except for those with severe heart failure. Catheter ablation can be considered as a first-line treatment in selected patients with lone AF.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app